+30.4%
GSK vs NTNX
+0.3%
+30.1%
-18.5%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 1y.
| Period | Portfolio | NTNX | Excess | Alpha |
|---|---|---|---|---|
| 1D | -1.9% | 0.0% | -1.9% | -1.9% |
| 7D | -1.8% | -1.6% | -0.2% | -1.8% |
| 30D | -2.2% | +11.6% | -13.8% | -2.1% |
| 3M | -1.8% | +23.8% | -25.6% | -1.7% |
| 6M | -10.6% | +68.8% | -79.4% | -10.2% |
| YTD | +4.4% | +31.7% | -27.2% | +5.1% |
| 1Y | +30.4% | -0.9% | +31.3% | +30.5% |
| All | +30.4% | +0.3% | +30.1% | +30.5% |
Cumulative growth
Daily Returns
Daily percentage return beside NTNX.
Daily Out/Under-Performance
Portfolio return minus NTNX return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × NTNX return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 1y: compounded portfolio wealth divided by compounded NTNX wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
1y analysis · Full analysis span regression · 6 months rolling